Philippe Corcia

CHU Bretonneau 2 Boulevard TONNELLE
Tours, 37044, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 269 publications

Exploring the effect of red and near-infrared light on neurodegenerative disease: A focus on amyotrophic lateral sclerosis, Charcot's devastating disease of the motor system.

Exploring the effect of red and near-infrared light on neurodegenerative disease: A focus on amyotrophic lateral sclerosis, Charcot's devastating disease of the motor system.

Journal: International review of neurobiology

Published: August 18, 2026

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Tofersen Treatment in SOD1-ALS: Real-World Evidence from a Retrospective Multicenter Study in France (FORSLA Study).

Journal: Mayo Clinic proceedings. Innovations, quality & outcomes

Published: August 04, 2026

ALS: An Organism-Wide Bioenergetic Failure Due to Mitochondrial Dysfunctions?

ALS: An Organism-Wide Bioenergetic Failure Due to Mitochondrial Dysfunctions?

Journal: Biomolecules

Published: June 18, 2026

Reversible & Microbubble Concentration-Dependent Permeabilization of an In Vitro Human Endothelial Barrier to Small Molecules Using Ultrasound: Implications for Neurodegenerative Diseases Therapy.

Reversible & Microbubble Concentration-Dependent Permeabilization of an In Vitro Human Endothelial Barrier to Small Molecules Using Ultrasound: Implications for Neurodegenerative Diseases Therapy.

Journal: Molecular pharmaceutics

Published: June 06, 2026

Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model.

Intrabody B1 targeting TDP-43 modulates neuroinflammatory and metabolic pathways in a preclinical ALS model.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: April 17, 2026

From Mutation to Manifestation: Penetrance in Amyotrophic Lateral Sclerosis.

From Mutation to Manifestation: Penetrance in Amyotrophic Lateral Sclerosis.

Journal: Genes

Published: April 07, 2026

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Primary Lateral Sclerosis French National Diagnostic and Care Protocol.

Journal: Revue neurologique

Published: April 01, 2026

ALS motor phenotypes: a revised 'OPM' classification.

ALS motor phenotypes: a revised 'OPM' classification.

Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration

Published: March 17, 2026

Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS Cohort.

Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS Cohort.

Journal: Molecular neurobiology

Published: February 03, 2026

Clinical Features and Prognosis of SEPTIN9-Related Hereditary Neuralgic Amyotrophy.

Clinical Features and Prognosis of SEPTIN9-Related Hereditary Neuralgic Amyotrophy.

Journal: European journal of neurology

Published: January 29, 2026

The preclinical discovery and development of edaravone for the treatment of amyotrophic lateral sclerosis: what lessons have we learnt?

The preclinical discovery and development of edaravone for the treatment of amyotrophic lateral sclerosis: what lessons have we learnt?

Journal: Expert opinion on drug discovery

Published: January 22, 2026

The economic burden of amyotrophic lateral sclerosis for patients and families: a survey on out-of-pocket expenses and income loss in France.

The economic burden of amyotrophic lateral sclerosis for patients and families: a survey on out-of-pocket expenses and income loss in France.

Journal: Orphanet journal of rare diseases

Published: November 23, 2025

Showing 1-12 of 269

Last Updated: 09/26/2026